Accent Microcell Ltd IPO: Global Presence & Financial Insights

Accent Microcell Limited, established in 2001, specializes in manufacturing and supplying excipients, primarily Microcrystalline Cellulose (MCC). Operating in 45+ countries, their focus on pharmaceuticals, nutraceuticals, food, and cosmetics has contributed to their recognized presence in the industry.

The company's IPO is set from December 8 to 12, 2023, at Rs.133 to Rs.140 per share, aiming for listing on December 15, 2023. With a total issue size of Rs.78.40 CR, 35% is allocated to retail investors.

Accent Microcell Limited showcases significant financial growth in FY 23, with assets at Rs. 12,214.89 lakhs and Profit After Tax (PAT) at Rs. 705.53 lakhs. Their revenue distribution by product is approximately 73% pharmaceuticals, 11% nutraceuticals, and 17% food, while geographically, 38.42% comes from domestic sales and 61.58% from exports.

The IPO's objectives include setting up a factory for various products and covering regular company expenses. Promoters like Mr. Vasant Vadilal Patel and others hold 73.13% pre-issue shareholding.

Accent Microcell Limited is managed by Corporate Capitalventures Pvt Ltd and stands alongside peers like Sigachi Industries Limited in terms of face value, P/E ratio, and EPS.

Despite strengths in global presence, product specialization, and diversification in revenue, the company faces weaknesses regarding its revenue reliance on the pharmaceutical sector and exposure to international market uncertainties.

The Grey Market Premium (GMP) for the Accent Microcell SME IPO stands at Rs.120, signaling early interest. However, investors should conduct thorough research before making investment decisions.

Explore Accent Microcell Limited IPO Now.